CIRM provides funding across five key areas: Infrastructure, Education, Discovery Research, Translational Research, and Clinical Research. By supporting projects at every stage of development, from initial discovery to clinical trials, CIRM drives progress in regenerative medicine and accelerates innovative therapies to patients.
Check out our portfolio of awards below. Click here to see a list of People We’ve Funded. Click here to see a list of our Funded Institutions.
All CIRM Grants
Search Filters »
| Institution |
Researcher name |
Grant Type |
Grant Title |
Award Value |
| HEALIOS NA, Inc. |
Dr. Norihiro Tsuneyoshi |
Tool Translational Research Projects |
Generation of human universal donor iPS cells |
$979,189 |
| University of California, Davis |
Dr Jan A Nolta |
Tool Translational Research Projects |
T-Pure: Peripheral Blood Processing Tool for Point of Care CAR-T Manufacturing |
$1,217,954 |
| Greenstone Biosciences, Inc. |
Paul D Pang |
Tool Translational Research Projects |
Cell Villages and Clinical Trial in a Dish with Pooled iPSC-CMs for Drug Discovery |
$1,350,000 |
| Organos, Inc. |
Samuel Wall |
Tool Translational Research Projects |
Human iPSC-derived micro-heart muscles for high-throughput cardiac drug discovery |
$1,119,382 |
| University of California, Davis |
Aijun Wang PhD |
Medical Device Translational Research Projects |
Living Synthetic Vascular Grafts with Renewable Endothelium |
$3,082,579 |
| Cedars-Sinai Medical Center |
Yuan Yuan |
Diagnostic Translational Research Projects |
A Rapid Clinical Digital Patient-derived Organoid to Guide Breast Cancer Treatment Decision |
$1,535,375 |
| Stanford University |
Sergiu P Pasca |
Therapeutic Translational Research Projects |
A targeted antisense oligonucleotide therapeutic strategy for Timothy syndrome |
$5,596,629 |
| University of California, Irvine |
Dr. Michael Demetriou |
Therapeutic Translational Research Projects |
GlyTR2 CAR T cell translation: safe pan-cancer killing via velcro-like density-dependent targeting of cancer glycans |
$4,581,144 |
| University of California, San Francisco |
Gregory Maness Allen |
Therapeutic Translational Research Projects |
FM-IL2 CAR T cells for Pancreatic Cancer |
$5,644,776 |
| Entos Pharmaceuticals |
John Lewis |
Therapeutic Translational Research Projects |
Lep001 – gene therapy for the treatment of congenital lipodystrophy |
$4,000,000 |
| Navega Therapeutics |
Ana Maria Moreno |
Therapeutic Translational Research Projects |
Development of an AAV Epigenetic Gene Therapy for Gain-of-Function SCN9A Disorders and Chronic Pain |
$3,982,633 |
| University of California, Los Angeles |
Roger Hollis |
Therapeutic Translational Research Projects |
Evaluation of an ex vivo lentiviral gene therapy for the treatment of Angelman syndrome |
$5,276,765 |
| ReviR Therapeutics |
Dr Paul R August |
Therapeutic Translational Research Projects |
Genetic Therapy Targeting mHTT mRNA and Somatic Expansion to Treat Huntington’s Disease |
$4,618,687 |
| University of Southern California |
David D. Tran |
Therapeutic Translational Research Projects |
A Novel Gene Therapy to Target Glioblastoma via Custom-Engineered Adenovirus-Associated Viral Vectors |
$5,927,454 |
| Nysno Bio |
Jennifer Johnston |
Therapeutic Translational Research Projects |
Parkin Gene Therapy for Parkinson’s Disease |
$2,450,510 |
| Maro Bio |
Akanksha Chhabra |
Therapeutic Translational Research Projects |
A novel non-genotoxic antibody conditioning therapeutic to expand access to and safety of HSCT and CD34+ gene therapies |
$4,043,427 |
| Neurona Therapeutics |
Dr. Cory R Nicholas |
Therapeutic Translational Research Projects |
Development of a universal allogeneic human interneuron cell therapy candidate for the treatment of drug resistant focal epilepsy. |
$3,828,714 |
| University of California, Los Angeles |
Dr. Donald B. Kohn |
Therapeutic Translational Research Projects |
Hematopoietic Stem Cell Gene Therapy for Alpha Thalassemia |
$5,028,351 |
| University of California, Los Angeles |
Dr. Lili Yang |
Therapeutic Translational Research Projects |
Combating Ovarian Cancer with Stem Cell-Engineered Off-The-Shelf CAR-NKT Cell Therapy |
$5,601,600 |
| Stanford University |
Natalia Gomez-Ospina |
Therapeutic Translational Research Projects |
Toward a Cure for Gaucher Disease Type 1: Autologous Transplantation of Genome Edited Hematopoietic Stem Cells |
$4,696,296 |
| AcuraStem Incorporated |
Mr. Samuel V. Alworth MS, MBA |
Therapeutic Translational Research Projects |
Development of AS-241, an UNC13A Targeting Antisense Oligonucleotide (ASO) Treatment for ALS, for IND-enabling Studies |
$4,012,325 |
| Axent Biosciences Inc. |
Rocio Sampayo |
Therapeutic Translational Research Projects |
A high quality, accessible cell therapy for Parkinson’s Disease produced in a scalable bioreactor system for 3D cell expansion and differentiation |
$3,999,241 |
| University of California, Los Angeles |
Dr. Gerald Lipshutz |
Therapeutic Translational Research Projects |
Development of a Gene Therapy for Treatment of Guanidinoacetate Methyltransferase Deficiency-Translating In Vivo Proof of Concept to Support a Pre-IND |
$5,145,825 |
| Ray Therapeutics, INC |
Paul Bresge |
Therapeutic Translational Research Projects |
Optogenetic Therapy for Treatment of Geographic Atrophy |
$3,998,930 |
| University of California, San Francisco |
Sarah Monica Knox |
Therapeutic Translational Research Projects |
Neurogenic hydrogel stimulation of stem cells to regenerate radiation-damaged salivary glands |
$2,312,021 |
| Cedars-Sinai Medical Center |
Dr. Ahmed Gamal Ibrahim |
Therapeutic Translational Research Projects |
Noncoding RNA drug TY1 as a therapeutic candidate for scleroderma and systemic sclerosis |
$2,590,224 |
| University of California, San Diego |
Dr Karen Christman |
Therapeutic Translational Research Projects |
Pro-regenerative infusible ECM biomaterial for treating acute myocardial infarction |
$4,353,438 |
| University of California, Los Angeles |
Zulema Romero Garcia |
Therapeutic Translational Research Projects |
Adenine Base Editing for Autologous Hematopoietic Stem Cell Gene Therapy of CD3δ SCID |
$5,966,928 |
| University of California, San Diego |
Dr. Eric D. Adler MD |
Therapeutic Translational Research Projects |
Ex Vivo Modified Hematopoietic Stem Cells to Treat Danon Disease |
$5,180,389 |
| University of California, Los Angeles |
Dr. Caroline Y. Kuo |
Therapeutic Translational Research Projects |
Hematopoietic Stem Cell Gene Editing for X-linked Agammaglobulinemia (XLA) |
$4,304,883 |
| University of California, Los Angeles |
Dr. Gerald Lipshutz |
Therapeutic Translational Research Projects |
Development of a Gene Therapy for the Treatment of Arginase Deficiency – Translating from Proof of Concept to Support Pre-IND Meeting |
$5,266,504 |
| City of Hope, Beckman Research Institute |
Dr Michael A. Caligiuri |
Therapeutic Translational Research Projects |
Targeting multiple myeloma with BCMA-CAR NK cells expressing a GPRC5D-NKG2D bispecific antibody |
$6,036,001 |
| University of California, Los Angeles |
Anthony J Aldave |
Therapeutic Translational Research Projects |
AAV Gene Therapy for Treating Congenital Hereditary Endothelial Dystrophy associated with Biallelic SLC4A11 Mutations |
$4,338,166 |
| ImmunoVec |
Luke Riggan |
Therapeutic Translational Research Projects |
Hematopoietic Stem Cell Gene Therapy for Wiskott Aldrich Syndrome |
$3,999,899 |
| BrainXell Therapeutics, Inc. |
Maria Daniela Cirnaru |
Therapeutic Translational Research Projects |
Development of Autologous Cell Replacement Therapy for Parkinson’s Disease: Path to Personalized Treatment |
$3,841,110 |
| University of California, Los Angeles |
Dr. Sophie X Deng |
Therapeutic Translational Research Projects |
Extracellular Vesicle-Based Therapy for Corneal Scars |
$5,779,276 |
| University of California, Los Angeles |
Dr. Scott G Kitchen |
Therapeutic Translational Research Projects |
Hematopoietic Stem/Progenitor Cell-Based Chimeric Antigen Receptor Gene Therapy for HIV Infection |
$6,140,723 |
| Rejuvenation Technologies, Inc. |
John Ramunas |
Therapeutic Translational Research Projects |
Telomerase mRNA for short telomere related pulmonary fibrosis |
$3,984,942 |
| University of Southern California |
Dr. Rongfu Wang |
Therapeutic Translational Research Projects |
Novel T cell receptor-STEM T cell immunotherapy in lung cancer |
$5,689,540 |
| Stanford University |
Walter Park |
Therapeutic Translational Research Projects |
Enhanced Autologous Pancreatic Islet Transplantation and Survival for Diabetes Mellitus Therapy |
$6,054,165 |
| University of California, Irvine |
Jianhua Yu |
Therapeutic Translational Research Projects |
Specific Targeting Hypoxia Metastatic Breast Tumor with Allogeneic Off-the-Shelf Anti-EGFR CAR NK Cells Expressing an ODD domain of HIF-1α |
$4,769,410 |
| University of California, San Diego |
Stephanie Cherqui |
Therapeutic Translational Research Projects |
CRISPR/Cas9-mediated gene editing of Hematopoietic stem and progenitor cells for Friedreich’s ataxia |
$4,846,579 |
| University of Southern California |
Preet M Chaudhary |
Therapeutic Translational Research Projects |
Next generation affinity-tuned CAR for prostate cancer |
$5,805,144 |
| University of California, Los Angeles |
Dr. Donald B. Kohn |
Therapeutic Translational Research Projects |
Autologous MPO Knock-Out Hematopoietic Stem and Progenitor Cells for Pulmonary Arterial Hypertension |
$4,751,297 |
| University of California, Irvine |
Dr. Aileen J Anderson |
Therapeutic Translational Research Projects |
A human neural stem cell therapeutic candidate for the treatment of chronic cervical spinal cord injury |
$4,950,024 |
| MyoGene Bio LLC |
Dr Courtney S Young |
Therapeutic Translational Research Projects |
Development of MyoDys45-55, a gene editing therapy for Duchenne muscular dystrophy |
$3,400,000 |
| ImmunoVec |
Luke Riggan |
Therapeutic Translational Research Projects |
Hematopoietic Stem Cell Gene Therapy for IPEX Syndrome |
$3,551,332 |
| Palo Alto Veterans Institute for Research |
Irene Lorenzo Llorente |
Therapeutic Translational Research Projects |
Clinical Translation of Allogenic Regenerative Cell Therapy for White Matter Stroke and Vascular Dementia |
$5,149,913 |
| University of California, Los Angeles |
Cristina Puig Saus |
Therapeutic Translational Research Projects |
CAR-Tnm cell therapy for melanoma targeting TYRP-1 |
$5,904,462 |
| University of California, Irvine |
Dr. Brian J. Cummings |
Therapeutic Translational Research Projects |
An optimized human neural stem cell line (hNSC) for the treatment of traumatic brain injury (TBI) |
$4,804,737 |
